Can Sanofi Catch Up With Amgen Now That Praluent Has CV Risk-Reduction Claim?

 
• By Joseph Haas
  
Risk Reduction words on puzzle pieces to illustrate a solution or mitigation of danger, hazard, liability or injury
Like Repatha, Praluent now has CV outcomes data in its US label.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cardiovascular

More from Therapeutic Category